What is the treatment of the lateral neck in clinically localized sporadic medullary thyroid cancer?

Laryngoscope

Volumn 120, Issue 7, 2010, Pages 1286-1287

  Witt, Robert L ^a,b  

^a HELEN F GRAHAM CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; NECK METASTASIS; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SHORT SURVEY; THYROID MEDULLARY CARCINOMA; TREATMENT FAILURE; TREATMENT INDICATION;

CARCINOMA, MEDULLARY; HUMANS; NECK DISSECTION; PRACTICE GUIDELINES AS TOPIC; THYROID NEOPLASMS;

EID: 77954401664     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20939     Document Type: Short Survey

References (5)

1. Kloos RT, Eng C, Evans DB, et al; Medullary thyroid cancer: management guidelines of the American Thyroid Association. American Thyroid Association Guidelines Task Force. Thyroid 2009;19:565-612.
2. Weber T, Schilling T, Frank-Raue K, et al. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 2001;130:1044-1049. (Pubitemid 34014572)
3. Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C. Long-term prognosis of medullary thyroid carcinoma. Clin Endocrinol (Oxf) 2008;69:497-505.
4. Machens A, Schneyer U, Holzhausen HJ, Dralle H. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 2005;90: 2029-2034. (Pubitemid 40586235)
5. Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. British J Surg 2008;95:586-595.